A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019

Sofosbuvir and daclatasvir have been used successfully since 2013 for hepatitis C treatment. It has been shown by different studies that sofosbuvir can inhibit RNA polymerase of other positive-strand RNA viruses including Flaviviridae and Togaviridae. Homology between hepatitis C virus RNA polymeras...

Descripción completa

Detalles Bibliográficos
Autores principales: Shabani, M., Sadegh Ehdaei, B., Fathi, F., Dowran, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103737/
https://www.ncbi.nlm.nih.gov/pubmed/33976895
http://dx.doi.org/10.1016/j.nmni.2021.100895
_version_ 1783689358559150080
author Shabani, M.
Sadegh Ehdaei, B.
Fathi, F.
Dowran, R.
author_facet Shabani, M.
Sadegh Ehdaei, B.
Fathi, F.
Dowran, R.
author_sort Shabani, M.
collection PubMed
description Sofosbuvir and daclatasvir have been used successfully since 2013 for hepatitis C treatment. It has been shown by different studies that sofosbuvir can inhibit RNA polymerase of other positive-strand RNA viruses including Flaviviridae and Togaviridae. Homology between hepatitis C virus RNA polymerase and severe acute respiratory syndrome coronavirus 2 has also been established. The efficacy of sofosbuvir and daclatasvir as potential choices in treating patients with coronavirus disease 2019 and their recovery can be hypothesized.
format Online
Article
Text
id pubmed-8103737
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81037372021-05-07 A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019 Shabani, M. Sadegh Ehdaei, B. Fathi, F. Dowran, R. New Microbes New Infect Mini-Review Sofosbuvir and daclatasvir have been used successfully since 2013 for hepatitis C treatment. It has been shown by different studies that sofosbuvir can inhibit RNA polymerase of other positive-strand RNA viruses including Flaviviridae and Togaviridae. Homology between hepatitis C virus RNA polymerase and severe acute respiratory syndrome coronavirus 2 has also been established. The efficacy of sofosbuvir and daclatasvir as potential choices in treating patients with coronavirus disease 2019 and their recovery can be hypothesized. Elsevier 2021-05-07 /pmc/articles/PMC8103737/ /pubmed/33976895 http://dx.doi.org/10.1016/j.nmni.2021.100895 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Mini-Review
Shabani, M.
Sadegh Ehdaei, B.
Fathi, F.
Dowran, R.
A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019
title A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019
title_full A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019
title_fullStr A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019
title_full_unstemmed A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019
title_short A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019
title_sort mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019
topic Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103737/
https://www.ncbi.nlm.nih.gov/pubmed/33976895
http://dx.doi.org/10.1016/j.nmni.2021.100895
work_keys_str_mv AT shabanim aminireviewonsofosbuviranddaclatasvirtreatmentincoronavirusdisease2019
AT sadeghehdaeib aminireviewonsofosbuviranddaclatasvirtreatmentincoronavirusdisease2019
AT fathif aminireviewonsofosbuviranddaclatasvirtreatmentincoronavirusdisease2019
AT dowranr aminireviewonsofosbuviranddaclatasvirtreatmentincoronavirusdisease2019
AT shabanim minireviewonsofosbuviranddaclatasvirtreatmentincoronavirusdisease2019
AT sadeghehdaeib minireviewonsofosbuviranddaclatasvirtreatmentincoronavirusdisease2019
AT fathif minireviewonsofosbuviranddaclatasvirtreatmentincoronavirusdisease2019
AT dowranr minireviewonsofosbuviranddaclatasvirtreatmentincoronavirusdisease2019

Ejemplares similares